

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 5.51340939 |
| 2 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 4.99529369 |
| 3 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 4.99529369 |
| 4 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 4.99529369 |
| 5 | DNA deamination (GO:0045006) | 4.87409533 |
| 6 | regulation of meiosis I (GO:0060631) | 4.63668939 |
| 7 | positive regulation of chromosome segregation (GO:0051984) | 4.37281791 |
| 8 | protein prenylation (GO:0018342) | 4.33487887 |
| 9 | prenylation (GO:0097354) | 4.33487887 |
| 10 | double-strand break repair via nonhomologous end joining (GO:0006303) | 4.30572300 |
| 11 | non-recombinational repair (GO:0000726) | 4.30572300 |
| 12 | synapsis (GO:0007129) | 4.27947964 |
| 13 | maturation of SSU-rRNA (GO:0030490) | 4.15621665 |
| 14 | regulation of sister chromatid cohesion (GO:0007063) | 4.13725981 |
| 15 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.89749298 |
| 16 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.88353891 |
| 17 | DNA replication initiation (GO:0006270) | 3.87749618 |
| 18 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.84738074 |
| 19 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.76116122 |
| 20 | DNA strand elongation (GO:0022616) | 3.74761603 |
| 21 | kinetochore organization (GO:0051383) | 3.71078261 |
| 22 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.70089191 |
| 23 | IMP biosynthetic process (GO:0006188) | 3.64879586 |
| 24 | establishment of integrated proviral latency (GO:0075713) | 3.64159543 |
| 25 | mitochondrial RNA metabolic process (GO:0000959) | 3.62518248 |
| 26 | telomere maintenance via recombination (GO:0000722) | 3.60662947 |
| 27 | DNA unwinding involved in DNA replication (GO:0006268) | 3.60106377 |
| 28 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.59778127 |
| 29 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.58121711 |
| 30 | cullin deneddylation (GO:0010388) | 3.51941580 |
| 31 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.51628080 |
| 32 | negative regulation of ligase activity (GO:0051352) | 3.51628080 |
| 33 | viral transcription (GO:0019083) | 3.51004203 |
| 34 | kinetochore assembly (GO:0051382) | 3.50118666 |
| 35 | CENP-A containing nucleosome assembly (GO:0034080) | 3.48930690 |
| 36 | mitotic recombination (GO:0006312) | 3.48726158 |
| 37 | protein deneddylation (GO:0000338) | 3.45333920 |
| 38 | translational termination (GO:0006415) | 3.45110377 |
| 39 | chromatin remodeling at centromere (GO:0031055) | 3.40300182 |
| 40 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.37344841 |
| 41 | ribosome biogenesis (GO:0042254) | 3.33801075 |
| 42 | piRNA metabolic process (GO:0034587) | 3.33547523 |
| 43 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.33363661 |
| 44 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.31423510 |
| 45 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 3.30074822 |
| 46 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 3.30074822 |
| 47 | DNA replication checkpoint (GO:0000076) | 3.29738737 |
| 48 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.29625795 |
| 49 | ribosomal small subunit biogenesis (GO:0042274) | 3.29527508 |
| 50 | ribosomal large subunit biogenesis (GO:0042273) | 3.29109827 |
| 51 | DNA damage response, detection of DNA damage (GO:0042769) | 3.26191926 |
| 52 | pseudouridine synthesis (GO:0001522) | 3.25981981 |
| 53 | telomere maintenance via telomere lengthening (GO:0010833) | 3.23943952 |
| 54 | regulation of mitotic sister chromatid separation (GO:0010965) | 3.23224349 |
| 55 | regulation of mitotic sister chromatid segregation (GO:0033047) | 3.23224349 |
| 56 | regulation of sister chromatid segregation (GO:0033045) | 3.23224349 |
| 57 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.17484921 |
| 58 | mitotic metaphase plate congression (GO:0007080) | 3.16834781 |
| 59 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.14950765 |
| 60 | rRNA processing (GO:0006364) | 3.14757468 |
| 61 | nuclear pore complex assembly (GO:0051292) | 3.14415867 |
| 62 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.13935011 |
| 63 | DNA replication-independent nucleosome organization (GO:0034724) | 3.13935011 |
| 64 | nucleobase biosynthetic process (GO:0046112) | 3.13865742 |
| 65 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.13682696 |
| 66 | metaphase plate congression (GO:0051310) | 3.11745558 |
| 67 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.10908395 |
| 68 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.10134672 |
| 69 | protein localization to kinetochore (GO:0034501) | 3.09474788 |
| 70 | translational elongation (GO:0006414) | 3.09337691 |
| 71 | spindle checkpoint (GO:0031577) | 3.09095843 |
| 72 | IMP metabolic process (GO:0046040) | 3.07969479 |
| 73 | regulation of chromosome segregation (GO:0051983) | 3.07357776 |
| 74 | nuclear pore organization (GO:0006999) | 3.07316759 |
| 75 | mitotic spindle checkpoint (GO:0071174) | 3.07010064 |
| 76 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.06877651 |
| 77 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.06877651 |
| 78 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.06877651 |
| 79 | tRNA methylation (GO:0030488) | 3.06489743 |
| 80 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.05824527 |
| 81 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.05824527 |
| 82 | 7-methylguanosine mRNA capping (GO:0006370) | 3.05757270 |
| 83 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 3.05479018 |
| 84 | rRNA metabolic process (GO:0016072) | 3.04992404 |
| 85 | cotranslational protein targeting to membrane (GO:0006613) | 3.04177760 |
| 86 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.02875025 |
| 87 | mitotic nuclear envelope disassembly (GO:0007077) | 3.02654010 |
| 88 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.02614674 |
| 89 | protein targeting to ER (GO:0045047) | 3.01747997 |
| 90 | positive regulation of ligase activity (GO:0051351) | 3.01245836 |
| 91 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.99501847 |
| 92 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.98819739 |
| 93 | cell cycle G1/S phase transition (GO:0044843) | 2.98819739 |
| 94 | telomere maintenance (GO:0000723) | 2.98302208 |
| 95 | metallo-sulfur cluster assembly (GO:0031163) | 2.97908044 |
| 96 | iron-sulfur cluster assembly (GO:0016226) | 2.97908044 |
| 97 | establishment of viral latency (GO:0019043) | 2.97244516 |
| 98 | RNA capping (GO:0036260) | 2.96996412 |
| 99 | 7-methylguanosine RNA capping (GO:0009452) | 2.96996412 |
| 100 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.96407590 |
| 101 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.96407590 |
| 102 | respiratory chain complex IV assembly (GO:0008535) | 2.96371308 |
| 103 | telomere organization (GO:0032200) | 2.96277647 |
| 104 | translational initiation (GO:0006413) | 2.95919912 |
| 105 | meiotic chromosome segregation (GO:0045132) | 2.94558736 |
| 106 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.94511937 |
| 107 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.94263247 |
| 108 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.94263247 |
| 109 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.94263247 |
| 110 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.94263247 |
| 111 | negative regulation of sister chromatid segregation (GO:0033046) | 2.94263247 |
| 112 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.94243827 |
| 113 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.93674067 |
| 114 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.93128076 |
| 115 | negative regulation of chromosome segregation (GO:0051985) | 2.92724495 |
| 116 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.92644876 |
| 117 | protein sumoylation (GO:0016925) | 2.92595807 |
| 118 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.92577706 |
| 119 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.92577706 |
| 120 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.92535579 |
| 121 | mitotic sister chromatid cohesion (GO:0007064) | 2.92291661 |
| 122 | chaperone-mediated protein transport (GO:0072321) | 2.91644122 |
| 123 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.91494982 |
| 124 | negative regulation of RNA splicing (GO:0033119) | 2.90565494 |
| 125 | formation of translation preinitiation complex (GO:0001731) | 2.90537848 |
| 126 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.90054621 |
| 127 | spliceosomal snRNP assembly (GO:0000387) | 2.89034843 |
| 128 | histone mRNA metabolic process (GO:0008334) | 2.88593518 |
| 129 | purine nucleobase biosynthetic process (GO:0009113) | 2.88530088 |
| 130 | viral mRNA export from host cell nucleus (GO:0046784) | 2.86909129 |
| 131 | proteasome assembly (GO:0043248) | 2.86881270 |
| 132 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.86812413 |
| 133 | termination of RNA polymerase II transcription (GO:0006369) | 2.86479195 |
| 134 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.85620299 |
| 135 | rRNA modification (GO:0000154) | 2.85445068 |
| 136 | ribosome assembly (GO:0042255) | 2.82362716 |
| 137 | DNA duplex unwinding (GO:0032508) | 2.80913628 |
| 138 | protein localization to endoplasmic reticulum (GO:0070972) | 2.80369893 |
| 139 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.80199768 |
| 140 | establishment of chromosome localization (GO:0051303) | 2.80183140 |
| 141 | DNA geometric change (GO:0032392) | 2.79098267 |
| 142 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.78822456 |
| 143 | protein localization to chromosome, centromeric region (GO:0071459) | 2.78440337 |
| 144 | mismatch repair (GO:0006298) | 2.77951065 |
| 145 | regulation of histone H3-K9 methylation (GO:0051570) | 2.77575442 |
| 146 | intra-S DNA damage checkpoint (GO:0031573) | 2.77117961 |
| 147 | snRNA processing (GO:0016180) | 2.76579290 |
| 148 | RNA splicing, via transesterification reactions (GO:0000375) | 2.74260794 |
| 149 | protein K6-linked ubiquitination (GO:0085020) | 2.72994109 |
| 150 | mRNA splicing, via spliceosome (GO:0000398) | 2.72987105 |
| 151 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 2.72987105 |
| 152 | spliceosomal complex assembly (GO:0000245) | 2.72559492 |
| 153 | histone exchange (GO:0043486) | 2.72431128 |
| 154 | termination of RNA polymerase III transcription (GO:0006386) | 2.71893524 |
| 155 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.71893524 |
| 156 | DNA-templated transcription, termination (GO:0006353) | 2.71874798 |
| 157 | nuclear envelope disassembly (GO:0051081) | 2.71708335 |
| 158 | membrane disassembly (GO:0030397) | 2.71708335 |
| 159 | regulation of helicase activity (GO:0051095) | 2.68662328 |
| 160 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.68459502 |
| 161 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.68459502 |
| 162 | isotype switching (GO:0045190) | 2.68459502 |
| 163 | cellular protein complex disassembly (GO:0043624) | 2.68171875 |
| 164 | mRNA catabolic process (GO:0006402) | 2.68125703 |
| 165 | replication fork processing (GO:0031297) | 2.67244814 |
| 166 | RNA catabolic process (GO:0006401) | 2.66961085 |
| 167 | ncRNA processing (GO:0034470) | 2.66776262 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.42421611 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.20676192 |
| 3 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.82253674 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.25655728 |
| 5 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.00083264 |
| 6 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.91892110 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.85644955 |
| 8 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.85568528 |
| 9 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.77946629 |
| 10 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.76554122 |
| 11 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.71339783 |
| 12 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.70277814 |
| 13 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.66724994 |
| 14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.54079138 |
| 15 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.53657805 |
| 16 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.50378914 |
| 17 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.44445775 |
| 18 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.35703992 |
| 19 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.29928007 |
| 20 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.23553540 |
| 21 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.22846242 |
| 22 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.20426916 |
| 23 | VDR_22108803_ChIP-Seq_LS180_Human | 2.20378435 |
| 24 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.19369900 |
| 25 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.18995952 |
| 26 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.17160648 |
| 27 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.14332766 |
| 28 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.10314523 |
| 29 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.05000314 |
| 30 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04702476 |
| 31 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.03856860 |
| 32 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.03264373 |
| 33 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.02482853 |
| 34 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 2.01014831 |
| 35 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.97742618 |
| 36 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.96413543 |
| 37 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.94222250 |
| 38 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.90595465 |
| 39 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.89987318 |
| 40 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.89710910 |
| 41 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.88804207 |
| 42 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.86512282 |
| 43 | MYC_22102868_ChIP-Seq_BL_Human | 1.85214006 |
| 44 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.82561201 |
| 45 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.81441049 |
| 46 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.79610651 |
| 47 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.78545403 |
| 48 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.76266110 |
| 49 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.75321963 |
| 50 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73994577 |
| 51 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.71288310 |
| 52 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.71036446 |
| 53 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.70633305 |
| 54 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69933258 |
| 55 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.69323021 |
| 56 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.69240826 |
| 57 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.67855376 |
| 58 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.65847061 |
| 59 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.64542020 |
| 60 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.53856275 |
| 61 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.53003591 |
| 62 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.52886025 |
| 63 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.49178511 |
| 64 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.47313715 |
| 65 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.47145319 |
| 66 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.44748793 |
| 67 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.41872270 |
| 68 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.37312762 |
| 69 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.36454002 |
| 70 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.32911377 |
| 71 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.31399457 |
| 72 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.29022325 |
| 73 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.27243306 |
| 74 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.26102643 |
| 75 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.19104595 |
| 76 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.19104595 |
| 77 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.19104595 |
| 78 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.17922928 |
| 79 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.17834337 |
| 80 | EWS_26573619_Chip-Seq_HEK293_Human | 1.17189468 |
| 81 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.16792717 |
| 82 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.15877817 |
| 83 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.15734589 |
| 84 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.15123699 |
| 85 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.13850358 |
| 86 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.13826599 |
| 87 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12437078 |
| 88 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.11871982 |
| 89 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.10416909 |
| 90 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09709330 |
| 91 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08596537 |
| 92 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.08138700 |
| 93 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.06943094 |
| 94 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.06637379 |
| 95 | GATA1_22025678_ChIP-Seq_K562_Human | 1.05942962 |
| 96 | FUS_26573619_Chip-Seq_HEK293_Human | 1.04573792 |
| 97 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.03370291 |
| 98 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.01613359 |
| 99 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.00202929 |
| 100 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.98244269 |
| 101 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.97466332 |
| 102 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.97015213 |
| 103 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.95805788 |
| 104 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.95424553 |
| 105 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.94882626 |
| 106 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.94247452 |
| 107 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.93363070 |
| 108 | MYB_26560356_Chip-Seq_TH1_Human | 0.93206439 |
| 109 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.93190399 |
| 110 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.92702749 |
| 111 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.91011676 |
| 112 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90747674 |
| 113 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.90057113 |
| 114 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.89931879 |
| 115 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.89157547 |
| 116 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.88845492 |
| 117 | MYB_26560356_Chip-Seq_TH2_Human | 0.87772225 |
| 118 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.87365138 |
| 119 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.86344568 |
| 120 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.85570690 |
| 121 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.84833006 |
| 122 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.83866488 |
| 123 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.83418085 |
| 124 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.80715402 |
| 125 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.80122788 |
| 126 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.79681899 |
| 127 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79627372 |
| 128 | P300_19829295_ChIP-Seq_ESCs_Human | 0.79058248 |
| 129 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.76837309 |
| 130 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.72954123 |
| 131 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.70166549 |
| 132 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.68763204 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.18962638 |
| 2 | MP0008057_abnormal_DNA_replication | 4.18203765 |
| 3 | MP0010094_abnormal_chromosome_stability | 3.96987882 |
| 4 | MP0008058_abnormal_DNA_repair | 3.70971251 |
| 5 | MP0002396_abnormal_hematopoietic_system | 3.50647791 |
| 6 | MP0003111_abnormal_nucleus_morphology | 3.48875798 |
| 7 | MP0003718_maternal_effect | 3.42639593 |
| 8 | MP0003077_abnormal_cell_cycle | 3.26856165 |
| 9 | MP0004957_abnormal_blastocyst_morpholog | 3.10589441 |
| 10 | MP0008007_abnormal_cellular_replicative | 2.91361917 |
| 11 | MP0002102_abnormal_ear_morphology | 2.69648820 |
| 12 | MP0008789_abnormal_olfactory_epithelium | 2.31377029 |
| 13 | MP0006292_abnormal_olfactory_placode | 2.29591124 |
| 14 | MP0000490_abnormal_crypts_of | 2.18034776 |
| 15 | MP0003763_abnormal_thymus_physiology | 2.15733095 |
| 16 | MP0004808_abnormal_hematopoietic_stem | 2.10772634 |
| 17 | MP0000372_irregular_coat_pigmentation | 1.95630599 |
| 18 | MP0003786_premature_aging | 1.94557145 |
| 19 | MP0008932_abnormal_embryonic_tissue | 1.88989141 |
| 20 | MP0003950_abnormal_plasma_membrane | 1.87284785 |
| 21 | MP0002837_dystrophic_cardiac_calcinosis | 1.78534096 |
| 22 | MP0001919_abnormal_reproductive_system | 1.75357187 |
| 23 | MP0005394_taste/olfaction_phenotype | 1.73367663 |
| 24 | MP0005499_abnormal_olfactory_system | 1.73367663 |
| 25 | MP0002751_abnormal_autonomic_nervous | 1.72157580 |
| 26 | MP0003303_peritoneal_inflammation | 1.70502320 |
| 27 | MP0000350_abnormal_cell_proliferation | 1.68583423 |
| 28 | MP0003123_paternal_imprinting | 1.67261366 |
| 29 | MP0002398_abnormal_bone_marrow | 1.65453952 |
| 30 | MP0005075_abnormal_melanosome_morpholog | 1.61134270 |
| 31 | MP0005397_hematopoietic_system_phenotyp | 1.59244434 |
| 32 | MP0001545_abnormal_hematopoietic_system | 1.59244434 |
| 33 | MP0005671_abnormal_response_to | 1.59201576 |
| 34 | MP0001835_abnormal_antigen_presentation | 1.57263919 |
| 35 | MP0006035_abnormal_mitochondrial_morpho | 1.56698907 |
| 36 | MP0008877_abnormal_DNA_methylation | 1.56124046 |
| 37 | MP0006036_abnormal_mitochondrial_physio | 1.52879251 |
| 38 | MP0003121_genomic_imprinting | 1.52647779 |
| 39 | MP0000703_abnormal_thymus_morphology | 1.50641350 |
| 40 | MP0010352_gastrointestinal_tract_polyps | 1.49489475 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.48634986 |
| 42 | MP0003646_muscle_fatigue | 1.47698177 |
| 43 | MP0001764_abnormal_homeostasis | 1.45876075 |
| 44 | MP0010307_abnormal_tumor_latency | 1.45763399 |
| 45 | MP0005174_abnormal_tail_pigmentation | 1.45027018 |
| 46 | MP0006082_CNS_inflammation | 1.44037318 |
| 47 | MP0001730_embryonic_growth_arrest | 1.43522086 |
| 48 | MP0001529_abnormal_vocalization | 1.42584281 |
| 49 | MP0003186_abnormal_redox_activity | 1.40789148 |
| 50 | MP0000313_abnormal_cell_death | 1.39080691 |
| 51 | MP0002095_abnormal_skin_pigmentation | 1.37775624 |
| 52 | MP0002254_reproductive_system_inflammat | 1.36593552 |
| 53 | * MP0001293_anophthalmia | 1.35474496 |
| 54 | MP0002722_abnormal_immune_system | 1.34386113 |
| 55 | MP0002019_abnormal_tumor_incidence | 1.32829852 |
| 56 | MP0000685_abnormal_immune_system | 1.32330068 |
| 57 | MP0000689_abnormal_spleen_morphology | 1.31799754 |
| 58 | MP0009697_abnormal_copulation | 1.31410066 |
| 59 | MP0001800_abnormal_humoral_immune | 1.29153793 |
| 60 | MP0005380_embryogenesis_phenotype | 1.26660025 |
| 61 | MP0001672_abnormal_embryogenesis/_devel | 1.26660025 |
| 62 | MP0002938_white_spotting | 1.26094597 |
| 63 | MP0000716_abnormal_immune_system | 1.24874810 |
| 64 | MP0003984_embryonic_growth_retardation | 1.23110454 |
| 65 | MP0001697_abnormal_embryo_size | 1.22321507 |
| 66 | MP0002429_abnormal_blood_cell | 1.22050653 |
| 67 | MP0005395_other_phenotype | 1.21852057 |
| 68 | MP0002166_altered_tumor_susceptibility | 1.21630907 |
| 69 | MP0000358_abnormal_cell_content/ | 1.20651532 |
| 70 | MP0003937_abnormal_limbs/digits/tail_de | 1.19451928 |
| 71 | MP0002088_abnormal_embryonic_growth/wei | 1.19228655 |
| 72 | MP0002006_tumorigenesis | 1.18369696 |
| 73 | MP0002420_abnormal_adaptive_immunity | 1.18261732 |
| 74 | MP0001819_abnormal_immune_cell | 1.16270025 |
| 75 | MP0002452_abnormal_antigen_presenting | 1.14273933 |
| 76 | MP0004215_abnormal_myocardial_fiber | 1.11911000 |
| 77 | MP0002080_prenatal_lethality | 1.09405791 |
| 78 | MP0002723_abnormal_immune_serum | 1.06698802 |
| 79 | MP0000749_muscle_degeneration | 1.06086154 |
| 80 | * MP0004197_abnormal_fetal_growth/weight/ | 1.05465605 |
| 81 | MP0001853_heart_inflammation | 1.04988469 |
| 82 | * MP0002085_abnormal_embryonic_tissue | 1.04138337 |
| 83 | MP0005423_abnormal_somatic_nervous | 1.03644636 |
| 84 | * MP0002086_abnormal_extraembryonic_tissu | 1.03301258 |
| 85 | MP0000647_abnormal_sebaceous_gland | 1.03264008 |
| 86 | MP0002084_abnormal_developmental_patter | 1.02196949 |
| 87 | MP0000858_altered_metastatic_potential | 1.01016206 |
| 88 | MP0002277_abnormal_respiratory_mucosa | 0.98471387 |
| 89 | MP0003943_abnormal_hepatobiliary_system | 0.98140349 |
| 90 | MP0003787_abnormal_imprinting | 0.98066638 |
| 91 | MP0000566_synostosis | 0.97809354 |
| 92 | MP0000516_abnormal_urinary_system | 0.97088430 |
| 93 | MP0005367_renal/urinary_system_phenotyp | 0.97088430 |
| 94 | MP0000467_abnormal_esophagus_morphology | 0.96035230 |
| 95 | MP0003890_abnormal_embryonic-extraembry | 0.95363249 |
| 96 | MP0003221_abnormal_cardiomyocyte_apopto | 0.94234003 |
| 97 | MP0002132_abnormal_respiratory_system | 0.94232367 |
| 98 | MP0002160_abnormal_reproductive_system | 0.93735866 |
| 99 | MP0005000_abnormal_immune_tolerance | 0.93344531 |
| 100 | MP0001986_abnormal_taste_sensitivity | 0.92607582 |
| 101 | MP0002075_abnormal_coat/hair_pigmentati | 0.90000399 |
| 102 | * MP0002210_abnormal_sex_determination | 0.89883447 |
| 103 | MP0001119_abnormal_female_reproductive | 0.89526296 |
| 104 | MP0002233_abnormal_nose_morphology | 0.88504060 |
| 105 | MP0003567_abnormal_fetal_cardiomyocyte | 0.87725779 |
| 106 | MP0003806_abnormal_nucleotide_metabolis | 0.87264004 |
| 107 | MP0006054_spinal_hemorrhage | 0.87090912 |
| 108 | MP0000383_abnormal_hair_follicle | 0.85782305 |
| 109 | MP0003698_abnormal_male_reproductive | 0.84731951 |
| 110 | MP0003315_abnormal_perineum_morphology | 0.82088537 |
| 111 | MP0005076_abnormal_cell_differentiation | 0.81277433 |
| 112 | MP0000015_abnormal_ear_pigmentation | 0.80986504 |
| 113 | * MP0001145_abnormal_male_reproductive | 0.80939356 |
| 114 | MP0001984_abnormal_olfaction | 0.79818266 |
| 115 | MP0003136_yellow_coat_color | 0.79761787 |
| 116 | MP0002405_respiratory_system_inflammati | 0.79523519 |
| 117 | MP0004264_abnormal_extraembryonic_tissu | 0.78802769 |
| 118 | MP0005389_reproductive_system_phenotype | 0.78307342 |
| 119 | MP0000569_abnormal_digit_pigmentation | 0.77032774 |
| 120 | MP0005408_hypopigmentation | 0.76838944 |
| 121 | MP0000465_gastrointestinal_hemorrhage | 0.76502745 |
| 122 | MP0003941_abnormal_skin_development | 0.75852329 |
| 123 | MP0004133_heterotaxia | 0.74835648 |
| 124 | MP0005025_abnormal_response_to | 0.74422025 |
| 125 | MP0001186_pigmentation_phenotype | 0.74324667 |
| 126 | MP0002148_abnormal_hypersensitivity_rea | 0.74136582 |
| 127 | MP0001324_abnormal_eye_pigmentation | 0.74076332 |
| 128 | * MP0002161_abnormal_fertility/fecundity | 0.73849069 |
| 129 | MP0003195_calcinosis | 0.73574924 |
| 130 | MP0010155_abnormal_intestine_physiology | 0.73150275 |
| 131 | MP0003115_abnormal_respiratory_system | 0.72852507 |
| 132 | MP0001485_abnormal_pinna_reflex | 0.72184448 |
| 133 | MP0004084_abnormal_cardiac_muscle | 0.71200032 |
| 134 | MP0004233_abnormal_muscle_weight | 0.71148179 |
| 135 | MP0003436_decreased_susceptibility_to | 0.70349464 |
| 136 | MP0010030_abnormal_orbit_morphology | 0.68787102 |
| 137 | * MP0000653_abnormal_sex_gland | 0.68757955 |
| 138 | MP0002111_abnormal_tail_morphology | 0.68130213 |
| 139 | * MP0001286_abnormal_eye_development | 0.67891890 |
| 140 | MP0000371_diluted_coat_color | 0.67738870 |
| 141 | * MP0001929_abnormal_gametogenesis | 0.66965051 |
| 142 | MP0006072_abnormal_retinal_apoptosis | 0.66842781 |
| 143 | MP0003699_abnormal_female_reproductive | 0.66522291 |
| 144 | MP0005384_cellular_phenotype | 0.66336683 |
| 145 | MP0002009_preneoplasia | 0.66062415 |
| 146 | MP0001873_stomach_inflammation | 0.64955818 |
| 147 | MP0002419_abnormal_innate_immunity | 0.64263521 |
| 148 | MP0008995_early_reproductive_senescence | 0.63352388 |
| 149 | MP0003866_abnormal_defecation | 0.62884011 |
| 150 | MP0003119_abnormal_digestive_system | 0.62829964 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Birth length less than 3rd percentile (HP:0003561) | 4.30182326 |
| 2 | Reticulocytopenia (HP:0001896) | 3.99273939 |
| 3 | Abnormal number of erythroid precursors (HP:0012131) | 3.81068367 |
| 4 | Chromsome breakage (HP:0040012) | 3.77647265 |
| 5 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.63863962 |
| 6 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.57427693 |
| 7 | Aplastic anemia (HP:0001915) | 3.55817165 |
| 8 | Hypoplastic pelvis (HP:0008839) | 3.54127873 |
| 9 | Colon cancer (HP:0003003) | 3.22108816 |
| 10 | Dry hair (HP:0011359) | 3.19424253 |
| 11 | Increased serum pyruvate (HP:0003542) | 3.02999351 |
| 12 | Thrombocytosis (HP:0001894) | 3.01876430 |
| 13 | Abnormality of chromosome stability (HP:0003220) | 2.98128696 |
| 14 | 11 pairs of ribs (HP:0000878) | 2.86253663 |
| 15 | Myelodysplasia (HP:0002863) | 2.84395224 |
| 16 | Acute encephalopathy (HP:0006846) | 2.82878098 |
| 17 | Meckel diverticulum (HP:0002245) | 2.81617033 |
| 18 | Medulloblastoma (HP:0002885) | 2.76963705 |
| 19 | Acute necrotizing encephalopathy (HP:0006965) | 2.76666712 |
| 20 | Abnormality of the ileum (HP:0001549) | 2.75654144 |
| 21 | Type I transferrin isoform profile (HP:0003642) | 2.74580054 |
| 22 | Abnormality of the preputium (HP:0100587) | 2.70992125 |
| 23 | Abnormality of glycolysis (HP:0004366) | 2.70914467 |
| 24 | Progressive muscle weakness (HP:0003323) | 2.63053861 |
| 25 | Patellar aplasia (HP:0006443) | 2.62915701 |
| 26 | Abnormality of the columella (HP:0009929) | 2.61494112 |
| 27 | Abnormality of the labia minora (HP:0012880) | 2.61391737 |
| 28 | Abnormality of methionine metabolism (HP:0010901) | 2.60645606 |
| 29 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.58901349 |
| 30 | Methylmalonic acidemia (HP:0002912) | 2.58726820 |
| 31 | Pallor (HP:0000980) | 2.58351901 |
| 32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.57383705 |
| 33 | Oral leukoplakia (HP:0002745) | 2.56578419 |
| 34 | Limb hypertonia (HP:0002509) | 2.56382202 |
| 35 | Agnosia (HP:0010524) | 2.55317164 |
| 36 | Ectopic kidney (HP:0000086) | 2.53186154 |
| 37 | Premature graying of hair (HP:0002216) | 2.50792137 |
| 38 | Glioma (HP:0009733) | 2.50017164 |
| 39 | Abnormality of the fingertips (HP:0001211) | 2.48975308 |
| 40 | IgM deficiency (HP:0002850) | 2.48822816 |
| 41 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.47742578 |
| 42 | Increased CSF lactate (HP:0002490) | 2.47023211 |
| 43 | Microvesicular hepatic steatosis (HP:0001414) | 2.44518101 |
| 44 | Increased serum lactate (HP:0002151) | 2.43147086 |
| 45 | Acute lymphatic leukemia (HP:0006721) | 2.40339750 |
| 46 | Abnormality of the astrocytes (HP:0100707) | 2.40302182 |
| 47 | Astrocytoma (HP:0009592) | 2.40302182 |
| 48 | Increased hepatocellular lipid droplets (HP:0006565) | 2.40241692 |
| 49 | Selective tooth agenesis (HP:0001592) | 2.39421455 |
| 50 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.36470151 |
| 51 | Optic nerve coloboma (HP:0000588) | 2.35655015 |
| 52 | Lactic acidosis (HP:0003128) | 2.32862268 |
| 53 | Bone marrow hypocellularity (HP:0005528) | 2.32125361 |
| 54 | Lymphoma (HP:0002665) | 2.30614509 |
| 55 | Progressive macrocephaly (HP:0004481) | 2.29454227 |
| 56 | Calf muscle hypertrophy (HP:0008981) | 2.28366110 |
| 57 | Acute myeloid leukemia (HP:0004808) | 2.27637247 |
| 58 | Hypoplasia of the pons (HP:0012110) | 2.26069220 |
| 59 | Macrocytic anemia (HP:0001972) | 2.24146356 |
| 60 | Abnormal number of incisors (HP:0011064) | 2.22569338 |
| 61 | Small intestinal stenosis (HP:0012848) | 2.20811181 |
| 62 | Duodenal stenosis (HP:0100867) | 2.20811181 |
| 63 | Mitochondrial inheritance (HP:0001427) | 2.20732128 |
| 64 | Clubbing of toes (HP:0100760) | 2.20437665 |
| 65 | Abnormality of DNA repair (HP:0003254) | 2.19841931 |
| 66 | Absent thumb (HP:0009777) | 2.19469258 |
| 67 | Exercise-induced muscle cramps (HP:0003710) | 2.16672509 |
| 68 | Supernumerary spleens (HP:0009799) | 2.16599384 |
| 69 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.16109917 |
| 70 | Abnormal protein glycosylation (HP:0012346) | 2.15465351 |
| 71 | Abnormal glycosylation (HP:0012345) | 2.15465351 |
| 72 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.15465351 |
| 73 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.15465351 |
| 74 | Sloping forehead (HP:0000340) | 2.14121934 |
| 75 | Amaurosis fugax (HP:0100576) | 2.12956638 |
| 76 | Adactyly (HP:0009776) | 2.11750448 |
| 77 | Prominent nose (HP:0000448) | 2.09000837 |
| 78 | Methylmalonic aciduria (HP:0012120) | 2.08702998 |
| 79 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.06540358 |
| 80 | Long eyelashes (HP:0000527) | 2.06121379 |
| 81 | Volvulus (HP:0002580) | 2.05337372 |
| 82 | Cerebral edema (HP:0002181) | 2.04713480 |
| 83 | Abnormality of the prostate (HP:0008775) | 2.04708056 |
| 84 | Lipid accumulation in hepatocytes (HP:0006561) | 2.02895048 |
| 85 | Female pseudohermaphroditism (HP:0010458) | 2.02881070 |
| 86 | Asplenia (HP:0001746) | 2.02820255 |
| 87 | Long foot (HP:0001833) | 2.01665127 |
| 88 | Hyperglycinemia (HP:0002154) | 2.01642751 |
| 89 | Abnormal ventriculo-arterial connection (HP:0011563) | 2.00246637 |
| 90 | Transposition of the great arteries (HP:0001669) | 2.00246637 |
| 91 | Abnormal connection of the cardiac segments (HP:0011545) | 2.00246637 |
| 92 | Abnormality of the carotid arteries (HP:0005344) | 1.98374559 |
| 93 | Ureteral duplication (HP:0000073) | 1.98238888 |
| 94 | Brushfield spots (HP:0001088) | 1.97018667 |
| 95 | Abnormality of the pons (HP:0007361) | 1.96940617 |
| 96 | Reduced antithrombin III activity (HP:0001976) | 1.96067789 |
| 97 | Neoplasm of the oral cavity (HP:0100649) | 1.96021207 |
| 98 | Type 2 muscle fiber atrophy (HP:0003554) | 1.95163590 |
| 99 | Short middle phalanx of the 5th finger (HP:0004220) | 1.94979546 |
| 100 | Triphalangeal thumb (HP:0001199) | 1.93904222 |
| 101 | Abnormality of the duodenum (HP:0002246) | 1.93003543 |
| 102 | Rectovaginal fistula (HP:0000143) | 1.92821505 |
| 103 | Rectal fistula (HP:0100590) | 1.92821505 |
| 104 | Abnormal lung lobation (HP:0002101) | 1.92574148 |
| 105 | Abnormality of the anterior horn cell (HP:0006802) | 1.92565465 |
| 106 | Degeneration of anterior horn cells (HP:0002398) | 1.92565465 |
| 107 | Renal cortical cysts (HP:0000803) | 1.91065604 |
| 108 | Rough bone trabeculation (HP:0100670) | 1.91005191 |
| 109 | Megaloblastic anemia (HP:0001889) | 1.90175752 |
| 110 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.88815696 |
| 111 | Muscle fiber atrophy (HP:0100295) | 1.88503442 |
| 112 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.87328902 |
| 113 | Cellular immunodeficiency (HP:0005374) | 1.86741440 |
| 114 | Pancytopenia (HP:0001876) | 1.85741296 |
| 115 | Breast hypoplasia (HP:0003187) | 1.85376014 |
| 116 | Neoplasm of the pancreas (HP:0002894) | 1.85019929 |
| 117 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.83560018 |
| 118 | Abnormality of homocysteine metabolism (HP:0010919) | 1.83110146 |
| 119 | Homocystinuria (HP:0002156) | 1.83110146 |
| 120 | Short tibia (HP:0005736) | 1.82576209 |
| 121 | Oligodactyly (hands) (HP:0001180) | 1.81877929 |
| 122 | Abnormality of serum amino acid levels (HP:0003112) | 1.81725393 |
| 123 | Ependymoma (HP:0002888) | 1.81512434 |
| 124 | Renal Fanconi syndrome (HP:0001994) | 1.81214507 |
| 125 | Rhabdomyosarcoma (HP:0002859) | 1.80838798 |
| 126 | Tracheoesophageal fistula (HP:0002575) | 1.79028256 |
| 127 | Exercise intolerance (HP:0003546) | 1.78824881 |
| 128 | Microretrognathia (HP:0000308) | 1.78710682 |
| 129 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.78591812 |
| 130 | Basal cell carcinoma (HP:0002671) | 1.77195116 |
| 131 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.77160507 |
| 132 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.77160507 |
| 133 | Duplicated collecting system (HP:0000081) | 1.77125474 |
| 134 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.76822722 |
| 135 | Hepatic necrosis (HP:0002605) | 1.76284772 |
| 136 | Abnormality of the renal collecting system (HP:0004742) | 1.74918276 |
| 137 | Nausea (HP:0002018) | 1.74136147 |
| 138 | Septate vagina (HP:0001153) | 1.73632451 |
| 139 | Carpal bone hypoplasia (HP:0001498) | 1.72947337 |
| 140 | Embryonal renal neoplasm (HP:0011794) | 1.72844633 |
| 141 | Exertional dyspnea (HP:0002875) | 1.72124467 |
| 142 | IgG deficiency (HP:0004315) | 1.71383835 |
| 143 | Cleft eyelid (HP:0000625) | 1.71381505 |
| 144 | Horseshoe kidney (HP:0000085) | 1.70933504 |
| 145 | Poor suck (HP:0002033) | 1.70826817 |
| 146 | Abnormality of vitamin B metabolism (HP:0004340) | 1.70467842 |
| 147 | Intestinal atresia (HP:0011100) | 1.70291050 |
| 148 | Secondary amenorrhea (HP:0000869) | 1.69360662 |
| 149 | Hyperalaninemia (HP:0003348) | 1.69221483 |
| 150 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.69221483 |
| 151 | Panhypogammaglobulinemia (HP:0003139) | 1.68718507 |
| 152 | Leukopenia (HP:0001882) | 1.68649221 |
| 153 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.67128643 |
| 154 | Increased nuchal translucency (HP:0010880) | 1.65684271 |
| 155 | Short thumb (HP:0009778) | 1.64551860 |
| 156 | Abnormality of T cell physiology (HP:0011840) | 1.62852733 |
| 157 | Recurrent viral infections (HP:0004429) | 1.62295212 |
| 158 | Abnormality of T cells (HP:0002843) | 1.59979878 |
| 159 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.59785616 |
| 160 | Chronic otitis media (HP:0000389) | 1.59298801 |
| 161 | B lymphocytopenia (HP:0010976) | 1.58629556 |
| 162 | Abnormality of B cell number (HP:0010975) | 1.58629556 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SRPK1 | 4.31136829 |
| 2 | CDC7 | 3.30977053 |
| 3 | WEE1 | 3.00923100 |
| 4 | TAOK1 | 2.69478475 |
| 5 | BUB1 | 2.67339115 |
| 6 | VRK2 | 2.56453732 |
| 7 | VRK1 | 2.52684390 |
| 8 | TRIM28 | 2.42912646 |
| 9 | STK16 | 2.40852038 |
| 10 | EIF2AK1 | 2.29219771 |
| 11 | BRD4 | 2.28433424 |
| 12 | ZAK | 2.22255717 |
| 13 | MKNK1 | 2.18100606 |
| 14 | TLK1 | 2.17378861 |
| 15 | MST4 | 2.16573259 |
| 16 | MKNK2 | 2.11364602 |
| 17 | ACVR1B | 2.09107895 |
| 18 | ATR | 2.07562938 |
| 19 | PBK | 2.06249477 |
| 20 | DYRK3 | 2.03556058 |
| 21 | NEK2 | 1.99190280 |
| 22 | NME2 | 1.97754147 |
| 23 | CDK12 | 1.92663376 |
| 24 | EIF2AK3 | 1.91056269 |
| 25 | PLK4 | 1.89458122 |
| 26 | CDK7 | 1.80594153 |
| 27 | TEC | 1.74332191 |
| 28 | BRSK2 | 1.63593754 |
| 29 | FLT3 | 1.60704658 |
| 30 | PASK | 1.59251777 |
| 31 | IRAK4 | 1.52962069 |
| 32 | TSSK6 | 1.51921112 |
| 33 | PLK1 | 1.43976246 |
| 34 | MAP4K1 | 1.43358207 |
| 35 | NEK1 | 1.42224160 |
| 36 | MAP3K3 | 1.42122030 |
| 37 | WNK3 | 1.39826668 |
| 38 | CHEK2 | 1.36260794 |
| 39 | PIM2 | 1.35725274 |
| 40 | RPS6KA4 | 1.34612335 |
| 41 | EIF2AK2 | 1.32210454 |
| 42 | AURKB | 1.29593674 |
| 43 | TTK | 1.28370757 |
| 44 | RPS6KB2 | 1.27726057 |
| 45 | TXK | 1.19814909 |
| 46 | PIM1 | 1.17069370 |
| 47 | PLK3 | 1.15012011 |
| 48 | EPHA2 | 1.13847803 |
| 49 | TNIK | 1.13739552 |
| 50 | PDK2 | 1.12668671 |
| 51 | BTK | 1.12455573 |
| 52 | TGFBR1 | 1.10104445 |
| 53 | STK10 | 1.07484628 |
| 54 | NME1 | 1.07041900 |
| 55 | ATM | 1.05063397 |
| 56 | CHEK1 | 1.04780435 |
| 57 | SIK3 | 1.02752594 |
| 58 | CCNB1 | 1.02023890 |
| 59 | KIT | 1.01607358 |
| 60 | MAP3K11 | 1.00010477 |
| 61 | NLK | 0.99537792 |
| 62 | STK4 | 0.98900955 |
| 63 | TAF1 | 0.93735662 |
| 64 | ABL2 | 0.92212157 |
| 65 | CDK4 | 0.91685647 |
| 66 | MAP3K5 | 0.89022219 |
| 67 | MAP3K14 | 0.88038560 |
| 68 | MAP3K4 | 0.87508504 |
| 69 | IKBKB | 0.84948644 |
| 70 | CDK8 | 0.84708789 |
| 71 | JAK3 | 0.82654375 |
| 72 | IRAK3 | 0.81973837 |
| 73 | PNCK | 0.81642888 |
| 74 | ZAP70 | 0.78304813 |
| 75 | CLK1 | 0.77903916 |
| 76 | MAP2K3 | 0.76739743 |
| 77 | BCR | 0.75998321 |
| 78 | CDK2 | 0.74684340 |
| 79 | RPS6KA5 | 0.74363788 |
| 80 | ERBB3 | 0.72742304 |
| 81 | MUSK | 0.72259873 |
| 82 | BCKDK | 0.71939657 |
| 83 | MAP2K7 | 0.70318119 |
| 84 | YES1 | 0.70073634 |
| 85 | TESK2 | 0.68080084 |
| 86 | CHUK | 0.65649377 |
| 87 | MAP3K8 | 0.65301599 |
| 88 | OXSR1 | 0.64879716 |
| 89 | AURKA | 0.64528046 |
| 90 | NEK9 | 0.63859009 |
| 91 | BLK | 0.63461280 |
| 92 | CSF1R | 0.61144461 |
| 93 | NUAK1 | 0.60093073 |
| 94 | CSNK2A2 | 0.59500537 |
| 95 | BRSK1 | 0.58457955 |
| 96 | CSNK1G1 | 0.58409789 |
| 97 | MAP4K2 | 0.58162613 |
| 98 | DYRK1A | 0.57706646 |
| 99 | CSNK2A1 | 0.57225828 |
| 100 | CSNK1G3 | 0.55088037 |
| 101 | CDK3 | 0.53885611 |
| 102 | CSNK1G2 | 0.53520882 |
| 103 | CDK1 | 0.52610760 |
| 104 | LYN | 0.52043496 |
| 105 | SYK | 0.51645173 |
| 106 | TAOK2 | 0.51302931 |
| 107 | GRK1 | 0.49050112 |
| 108 | ADRBK2 | 0.46597525 |
| 109 | MAPKAPK5 | 0.46464263 |
| 110 | FRK | 0.46244381 |
| 111 | STK38L | 0.46211713 |
| 112 | RPS6KB1 | 0.44356994 |
| 113 | MARK3 | 0.44133034 |
| 114 | SCYL2 | 0.43866814 |
| 115 | NEK6 | 0.43415659 |
| 116 | TYK2 | 0.40437607 |
| 117 | STK3 | 0.39144644 |
| 118 | KDR | 0.38743471 |
| 119 | IKBKE | 0.38348893 |
| 120 | LCK | 0.38270268 |
| 121 | PLK2 | 0.37296945 |
| 122 | EPHA4 | 0.36830826 |
| 123 | ERBB4 | 0.36118037 |
| 124 | PIK3CA | 0.35635681 |
| 125 | CDK19 | 0.35482004 |
| 126 | PRKDC | 0.35447152 |
| 127 | CDK6 | 0.34414778 |
| 128 | INSRR | 0.33903537 |
| 129 | CDK9 | 0.33385947 |
| 130 | FGR | 0.33208279 |
| 131 | PRKCI | 0.32859320 |
| 132 | MAPK14 | 0.32633964 |
| 133 | PAK3 | 0.31726401 |
| 134 | ITK | 0.30955247 |
| 135 | DYRK2 | 0.30148550 |
| 136 | RPS6KA6 | 0.29906688 |
| 137 | CSNK1A1 | 0.29793652 |
| 138 | RPS6KL1 | 0.29563253 |
| 139 | RPS6KC1 | 0.29563253 |
| 140 | CSNK1E | 0.29503420 |
| 141 | OBSCN | 0.28299323 |
| 142 | MAPK3 | 0.27872276 |
| 143 | CSNK1A1L | 0.27821057 |
| 144 | TAOK3 | 0.27728143 |
| 145 | MAP3K12 | 0.27603463 |
| 146 | MAPK13 | 0.23464522 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.25717693 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 3.63534408 |
| 3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.35789321 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.27313856 |
| 5 | Spliceosome_Homo sapiens_hsa03040 | 3.05660045 |
| 6 | Base excision repair_Homo sapiens_hsa03410 | 3.02597808 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 2.97686639 |
| 8 | Homologous recombination_Homo sapiens_hsa03440 | 2.90481333 |
| 9 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.67420838 |
| 10 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.60454985 |
| 11 | RNA transport_Homo sapiens_hsa03013 | 2.47860914 |
| 12 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.41318913 |
| 13 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.40725844 |
| 14 | Cell cycle_Homo sapiens_hsa04110 | 2.30363303 |
| 15 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.28380852 |
| 16 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.24903115 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.19826567 |
| 18 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.13295831 |
| 19 | RNA degradation_Homo sapiens_hsa03018 | 2.12989882 |
| 20 | Basal transcription factors_Homo sapiens_hsa03022 | 2.11463426 |
| 21 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.05621432 |
| 22 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.02141107 |
| 23 | Proteasome_Homo sapiens_hsa03050 | 2.00032159 |
| 24 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.88752231 |
| 25 | Parkinsons disease_Homo sapiens_hsa05012 | 1.82536423 |
| 26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.76653607 |
| 27 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.67938522 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.53674996 |
| 29 | Protein export_Homo sapiens_hsa03060 | 1.51570010 |
| 30 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.49609792 |
| 31 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.48235024 |
| 32 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.47833244 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.46316814 |
| 34 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.41062208 |
| 35 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.39635731 |
| 36 | Huntingtons disease_Homo sapiens_hsa05016 | 1.32949361 |
| 37 | Purine metabolism_Homo sapiens_hsa00230 | 1.29322833 |
| 38 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.27177313 |
| 39 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.21056249 |
| 40 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.12336923 |
| 41 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.10737066 |
| 42 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.07730707 |
| 43 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.07635356 |
| 44 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.07313323 |
| 45 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.05305852 |
| 46 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.04943778 |
| 47 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.04009762 |
| 48 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.02284058 |
| 49 | Measles_Homo sapiens_hsa05162 | 1.01446156 |
| 50 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.92177539 |
| 51 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.90997039 |
| 52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.90776131 |
| 53 | Alzheimers disease_Homo sapiens_hsa05010 | 0.87215294 |
| 54 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.86971655 |
| 55 | HTLV-I infection_Homo sapiens_hsa05166 | 0.85158460 |
| 56 | Carbon metabolism_Homo sapiens_hsa01200 | 0.82837321 |
| 57 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.80800769 |
| 58 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.78011086 |
| 59 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.77543071 |
| 60 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.76042455 |
| 61 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.75065032 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.74503778 |
| 63 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.73860112 |
| 64 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.72655918 |
| 65 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.72547457 |
| 66 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.72240707 |
| 67 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.70765054 |
| 68 | Allograft rejection_Homo sapiens_hsa05330 | 0.68200723 |
| 69 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.68121818 |
| 70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.66293629 |
| 71 | Hepatitis B_Homo sapiens_hsa05161 | 0.64676432 |
| 72 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.64061447 |
| 73 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.63823826 |
| 74 | Legionellosis_Homo sapiens_hsa05134 | 0.62335074 |
| 75 | Apoptosis_Homo sapiens_hsa04210 | 0.61028197 |
| 76 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.60688971 |
| 77 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.59799903 |
| 78 | Alcoholism_Homo sapiens_hsa05034 | 0.59012847 |
| 79 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.58990903 |
| 80 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.58019830 |
| 81 | Peroxisome_Homo sapiens_hsa04146 | 0.57884334 |
| 82 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.57753337 |
| 83 | Influenza A_Homo sapiens_hsa05164 | 0.57422515 |
| 84 | Leishmaniasis_Homo sapiens_hsa05140 | 0.56986700 |
| 85 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.56095624 |
| 86 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.55924087 |
| 87 | Thyroid cancer_Homo sapiens_hsa05216 | 0.55714640 |
| 88 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.55584452 |
| 89 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.55059544 |
| 90 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.54836797 |
| 91 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.52453531 |
| 92 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51727156 |
| 93 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.51528610 |
| 94 | Colorectal cancer_Homo sapiens_hsa05210 | 0.50771482 |
| 95 | Shigellosis_Homo sapiens_hsa05131 | 0.50489690 |
| 96 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.49987476 |
| 97 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.49927871 |
| 98 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.49207164 |
| 99 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.47376739 |
| 100 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.44515677 |
| 101 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.43003958 |
| 102 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.42514781 |
| 103 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.42456522 |
| 104 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.39685225 |
| 105 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39421629 |
| 106 | Sulfur relay system_Homo sapiens_hsa04122 | 0.39226146 |
| 107 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.39157157 |
| 108 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.38973697 |
| 109 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.38819577 |
| 110 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.38585752 |
| 111 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.38223883 |
| 112 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.37340889 |
| 113 | Asthma_Homo sapiens_hsa05310 | 0.37336696 |
| 114 | Phototransduction_Homo sapiens_hsa04744 | 0.37130457 |
| 115 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.36247445 |
| 116 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.35980145 |
| 117 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.35491639 |
| 118 | Lysine degradation_Homo sapiens_hsa00310 | 0.33738647 |
| 119 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.33330505 |
| 120 | Other glycan degradation_Homo sapiens_hsa00511 | 0.32780902 |
| 121 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.32189093 |
| 122 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.31897416 |
| 123 | Taste transduction_Homo sapiens_hsa04742 | 0.31548180 |
| 124 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.31463775 |
| 125 | Pathways in cancer_Homo sapiens_hsa05200 | 0.29638274 |
| 126 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.29447191 |
| 127 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.28291092 |
| 128 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.28072150 |
| 129 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.26989939 |
| 130 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.26810851 |
| 131 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.26781457 |
| 132 | Prostate cancer_Homo sapiens_hsa05215 | 0.25595762 |
| 133 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.25173664 |
| 134 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.23950433 |
| 135 | Viral myocarditis_Homo sapiens_hsa05416 | 0.23672962 |
| 136 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.23309392 |
| 137 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.23017178 |
| 138 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.21926599 |
| 139 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.21573271 |
| 140 | Galactose metabolism_Homo sapiens_hsa00052 | 0.21222989 |
| 141 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.20707830 |
| 142 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.12386547 |
| 143 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.12382953 |
| 144 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.09237799 |
| 145 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.08898905 |
| 146 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.06840275 |
| 147 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.06010490 |
| 148 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.04780875 |
| 149 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.04066836 |

